The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
Pancreatic cancer has the highest mortality rate of all major cancers, with a 5-year survival rate of about 10%. Early warning signs and symptoms of pancreatic cancer are vague or nonexistent, and most patients are diagnosed in Stage IV, when surgery is not an option for about 80%–85% of patients. F...
Main Authors: | Peng Dong MM, Yu Yan MM, Yujun Fan PhD, Hui Wang PhD, Danzhu Wu MM, Liyuan Yang MM, Junpeng Zhang PhD, Xiaoyang Yin PhD, Yajuan Lv MD, Jiandong Zhang MD, Yuzhu Hou PhD, Fengjun Liu MD, Xinshuang Yu MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338221142472 |
Similar Items
-
Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells
by: Yifan Duan MD, PhD, et al.
Published: (2020-04-01) -
B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis
by: Yunfen Zhou MD, et al.
Published: (2020-12-01) -
Tumor Suppressor Effect of RBMS3 in Breast Cancer
by: Chunyang Wang MD, PhD, et al.
Published: (2021-04-01) -
A Potential Tumor Suppressor Gene Named miR-508-5p Inhibited the Proliferation and Invasion of Human Melanoma Cells by Targeting KIT
by: Lin Dang PhD, et al.
Published: (2020-09-01) -
Comment on: “Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma”
by: Yangyang Zheng, MM, et al.
Published: (2023-03-01)